Healthy adult male and female
Conditions
Interventions
Take five capsules containing protein hydrolysate per dose.
Take five capsules without protein hydrolysate per dose.
Take ten capsules containing protein hydrolysate per dose.
Take ten capsules withou
Sponsors
IMEQRD Co., Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Healthy males and females from 20 to 60 years of age at the time of obtaining consent to participate in this study. 2) Subjects who can input data into the electronic logbook using a PC, smartphone, etc. 3) Subjects who can make self-judgment and are voluntarily giving written informed consent.
Exclusion criteria
Exclusion criteria: Subjects have a disease that accompanies mental and physical disorders such as chronic fatigue syndrome, etc. Subjects have undergone gastrointestinal surgery (excluding appendicitis). Subjects are currently taking over-the-counter drugs, quasi-drugs, foods for specified health uses, health foods, or supplements. Subjects take food for specified health use intended for effects on the autonomic nervous system, sleep, metabolism, and intestinal environment, food with function claims, healthy food, etc., or who cannot stop taking it during the test period. Subjects drink a lot of alcohol. Subjects have a smoking habit. Subjects with irregular life rhythms. Subjects may change their lifestyle. Subjects have had a life event that affects their mind and body within the past month. Subjects participated in a study involving the use other foods or drugs, or the application of cosmetics or drugs within one month prior to obtaining consent, or who will participate in another study while participating in this study. Subjects consume a large amount of milk, dairy products, or milk-derived protein every day. Subjects have a habit of doing strenuous exercise at least 3-4 times a week. Subjects have experienced poor mood or deterioration of physical condition due to blood collection. Subjects have donated 200 ml or more of whole blood within 3 months before obtaining consent. Subjects are currently undergoing regular hospital visits and treatment for any illness. Subjects have severe diseases in liver, kidney, heart, metabolic system, etc. Subjects have a history of treatment for heart failure, etc. Subjects may exhibit allergy symptoms to milk or soy, or those who have a lactose intolerant constitution. Subjects with current or past drug or food allergies. Subjects are pregnant or breastfeeding, and those who wish to become pregnant during the study period. Others subjects are judged to be inappropriate as research subjects by the principal investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Plasma acetyl-L-carnitine concentration | — |
Secondary
| Measure | Time frame |
|---|---|
| Plasma carnitine concentration, Plasma free fatty acid concentration, POMS2(Short version), Questionnaire for fatigue symptoms | — |
Countries
Japan
Contacts
Public ContactRyo Uchida
Ajinomoto Co., Inc. Functional Ingredients Development Group, Wellness Value Creation Center, Institute of Food Sciences
Outcome results
None listed